Tempus AI Sees Unusually High Options Volume (NASDAQ:TEM)

Tempus AI, Inc. (NASDAQ:TEM) was the target of unusually large options trading activity on Thursday. Stock traders acquired 11,239 call options on the stock. This is an increase of 120% compared to the average volume of 5,113 call options.

Analyst Ratings Changes

Several equities research analysts recently commented on TEM shares. Piper Sandler reissued a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Wolfe Research initiated coverage on shares of Tempus AI in a research report on Friday. They issued an “outperform” rating and a $60.00 target price for the company. Guggenheim initiated coverage on shares of Tempus AI in a report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Bank of America upped their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday. Finally, Loop Capital raised their target price on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $56.00.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the sale, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This represents a 2.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David R. Epstein sold 620 shares of the company’s stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $41.81, for a total value of $25,922.20. Following the completion of the transaction, the director now owns 27,894 shares in the company, valued at $1,166,248.14. This represents a 2.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 650,949 shares of company stock valued at $27,821,944 over the last ninety days.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the third quarter valued at about $30,000. Sandia Investment Management LP bought a new stake in shares of Tempus AI during the second quarter valued at approximately $136,000. Vestor Capital LLC acquired a new position in shares of Tempus AI in the third quarter valued at $153,000. Stifel Financial Corp bought a new position in Tempus AI in the third quarter worth $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI in the 3rd quarter valued at $258,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Trading Down 2.4 %

Tempus AI stock opened at $41.00 on Friday. The business has a 50-day simple moving average of $52.64. Tempus AI has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.